Apiam Animal Health — Shareholder Meeting (November 2024)
13 slides from Apiam Animal Health's shareholder meeting presentation, Nov 21, 2024
Slide 1: Managing Director's Address
Managing Director’s Address Annual General Meeting 21 November 2024
Slide 2: Apiam's Business Today
APIAM'S BUSINESS TODAY 80 330 CLINICS VETERINARIANS APIAM’S RURAL & REGIONAL CLINIC NETWORK BY STATE CLINICAL VET INTENSIVE ANIMAL SERVICES VET SERVICES 4 19 - Formerly named Dairy & Mixed Animal segment - Includes Beef Feedlot & Pigs segments - Companion & mixed animal veterinary - Services commerc
Slide 3: Clinical Vet Services
CLINICAL VET SERVICES Clinical Vet Services COMPANION & MIXED ANIMAL % of FY24 revenue VETERINARY CLINIC SERVICES B2C Companion animal / pet, equine & farm 78% model services clients • Full-range of veterinary services & products required for animal health & well-being • Most clinics providing emerg
Slide 4: Intensive Animal Vet Services
INTENSIVE ANIMAL VET SERVICES Intensive Animal Vet Services % of FY24 revenue BEEF FEEDLOT & PIGS B2B Commercial feedlot & pig customers 22% model TECHNOLOGY & DATA ANALYTICS DRIVE APIAM’S SERVICE AND PRODUCT OFFERING: Livestock veterinary - Veterinary consulting services services - Advanced diagnos
Slide 5: FY24 Performance Update
FY24 PERFORMANCE UPDATE Resilient revenues despite broader economic and cost-of- living issues; supported by a diversified veterinary model Earnings growth strategy implemented • improved operating model and clinic efficiencies • operating leverage & further synergies extracted from acquisitions • c
Slide 6: FY24 Results Summary
FY24 RESULTS SUMMARY • Resilient revenue growth Gross profit EBITDA • Like-For-Like (LFL) Group revenue Revenue 1 (underlying, (0.5)% excluding four restructured (underlying)1 $204.8m pre AASB 16) 1,2,3 clinics in Clinical Vet Services segment $137.3m $20.3m +6.2% vs pcp +9.6% vs pcp • Operating lev
Slide 7: Segment Summary - FY24
SEGMENT SUMMARY- FY24 CLINICAL VET INTENSIVE Dairy ANIMAL& Mixed VET animal segment trends remain resilient….. SERVICES SEGMENT SERVICES SEGMENTS Apiam’s Best Mates program added 1578 new animals from September 2023 to Feedlot + Pigs segment January 2024 (19.3% growth) FY22 FY23 FY24 performance % g
Slide 8: FY25 YTD Trading (Jul – Oct)
FY25 YTD TRADING (Jul – Oct) Resilient revenue performance continuing into FY25 despite cost-of-living and broader economic challenges FY25 YTD FY24 YTD $M1 % chg (Jul-Oct) (Jul-Oct) Revenue 70.2 69.8 +0.5% Gross profit 46.7 46.9 -0.4% Operating expenses 38.3 38.3 +0.1% • EBITDA (underlying) Here ar
Slide 9: FY25 YTD Trading (Jul – Oct) (continued)
FY25 YTD TRADING (Jul – Oct) (continued) Core veterinary businesses continue to perform in-line with expectations Clinical Vet Services Segment FY25 YTD • Segment revenue growth FY25 YTD: +1.9% vs pcp1 • Companion, mixed animal & dairy revenue growth FY25 YTD: +3.3% vs pcp • Companion animal revenue
Slide 10: ACE Laboratories Driving Innovation & Growth
ACE LABORATORIES DRIVING INNOVATION & GROWTH Acquisition of ACE Laboratories in FY20 and subsequent investment is driving strong growth opportunities across both Clinical Vet Services and Intensive Animal businesses Vaccines Current vaccine expansion • Permit approval of four new vaccines - Histophi
Slide 11: Organic Growth Strategy Initiatives - FY25 Update
ORGANIC GROWTH STRATEGY INITIATIVES - FY25 UPDATE CLINICAL VET SERVICES INTENSIVE ANIMAL VET SERVICES GROWTH DRIVERS IN FY25 GROWTH DRIVERS IN FY25 Working towards all clinics in network meeting Group target Leverage investment made in software technology across margins. Continue to work to resolve
Slide 12: Outlook
OUTLOOK LOOKING AHEAD • Veterinary services remains resilient in rural and regional locations - Supported by Apiam’s diversified Clinical Vet Services (B2C) and Intensive Animal Vet Services (B2B) model • Management remain focused on driving both revenue opportunities + further efficiencies at clini
Slide 13: Disclaimer
Disclaimer DISCLAIMER The information presented to you by Apiam Animal Health Limited ACN 604 961 024 (Company) in this presentation and any related documents (together, Materials) has been prepared for information purposes only and is not an offer or invitation to acquire or dispose of shares in th
Apiam Animal Health — Shareholder Meeting (November 2024) on 6ix